SONMNasdaqTelephone & Telegraph ApparatusFiscal year ends December 31
DNA X, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$3.31+0.04 (+1.22%)
Close on Oct 19, 2026
- Market cap
- $4.47M
- P/E (TTM)
- –
- Dividend yield
- –
DNA X, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | TTM Q2 23 | TTM Q1 23 | TTM Q4 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smartphones | $30.37M | $30.21M | $31.75M | $26.30M | $27.64M | $28.04M | $30.54M | $31.41M | $30.53M | $23.67M | $20.66M | $17.76M | 51.4% | +9.9% |
| Feature Phones | $18.07M | $21.05M | $21.93M | $20.46M | $18.87M | $16.99M | $15.30M | $15.77M | $13.40M | $13.27M | $16.26M | $21.25M | 30.6% | -4.2% |
| Connected Solutions | $10.03M | $6.08M | – | $3.43M | – | – | – | – | – | – | – | – | 17.0% | – |
| Accessories and Other | $917.00K | $848.00K | $1.01M | $729.00K | $1.58M | $1.77M | $1.55M | $1.64M | $921.00K | $838.00K | $713.00K | $1.34M | 1.6% | -41.9% |
| Product [Member] | – | – | – | $58.29M | $56.73M | $69.28M | $84.60M | $93.63M | $104.31M | $97.25M | $82.35M | $69.80M | – | – |
| Service [Member] | – | – | – | $8.00K | $11.00K | $11.00K | $8.00K | $4.00K | – | – | – | $31.00K | – | – |
| Tablets [Member] | – | – | – | – | – | – | – | – | – | – | – | $29.48M | – | – |
| White Label Tablets | – | – | – | – | – | – | – | $44.82M | – | – | – | – | – | – |
By region
| Revenue | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | TTM Q2 23 | TTM Q1 23 | TTM Q4 22 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $45.94M | $45.85M | $45.23M | $39.73M | $36.00M | $36.13M | $35.30M | $33.18M | $30.70M | $23.25M | $23.54M | $29.44M | 77.7% | +27.6% |
| Canada | $7.19M | $7.75M | $9.68M | $9.10M | $10.46M | $8.99M | $9.64M | $10.57M | – | – | – | – | 12.2% | -31.3% |
| Europe and Middle East | $4.40M | $2.65M | $1.64M | $642.00K | $1.42M | $1.43M | $2.26M | $4.30M | $3.04M | $3.22M | $2.93M | $1.20M | 7.4% | +209.9% |
| Asia Pacific | $1.58M | $1.67M | $1.70M | $8.83M | $8.87M | $22.75M | $37.42M | $45.58M | $60.26M | $60.31M | $45.57M | $30.21M | 2.7% | -82.2% |
| Canada and Latin America | – | – | – | – | – | – | – | $10.57M | $10.32M | $10.47M | $10.33M | $8.98M | – | – |
From the segment and revenue-disaggregation notes of DNA X's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.